SummaryBronchiolitis obliterans syndrome (BOS) represents the leading cause of late mortality after lung transplantation (LTx). Cystic fibrosis (CF) patients frequently show airway colonization with gram-negative bacteria (GNB) both before and after LTx. Graft colonization with GNB and its relevance towards BOS development were investigated in a CF population after LTx.Adult CF patients receiving LTx and surviving at least 6 months were included in this prospective observational study between 1/1/2002 and 30/6/2006 in a single center and followed until 31/3/2007. Pre- and post-LTx respiratory culture samples were compared for the presence of identical GNB. BOS-free survival was compared in colonized and non-colonized patients.Fifty-nine adu...
Lung transplantation is the treatment of choice for patients with end-stage lung disease. However, l...
AbstractPatients with cystic fibrosis pose particular challenges for lung transplantation surgeons. ...
Bronchiolitis obliterans syndrome (BOS) is a pulmonary complication of allogeneic hematopoietic cell...
SummaryBronchiolitis obliterans syndrome (BOS) represents the leading cause of late mortality after ...
Abstract Background Chronic Lung Allograft Dysfunction (CLAD) is the main cause of morbidity and mor...
Bronchiolitis obliterans syndrome (BOS) is the main and late chronic complication after lung transpl...
BACKGROUND Acute cellular rejection (ACR) affects up to 40% of recipients within the first year afte...
International Conference of the American-Thoracic-Society (ATS), Washington, DC, MAY 19-24, 2017Inte...
Abstract Background While lung transplant (LTX) can be an effective therapy to provide the survival ...
Rationale: Bronchiolitis obliterans syndrome (BOS) is the primary limiting factor for long-term surv...
Rationale: Lung transplantation offers the only survival option for patients with cystic fibrosis (C...
Burkholderia cepacia complex (Bcc) includes several phenotypically similar but genotypically distinc...
Lung transplantation can be lifesaving in end-stage cystic fibrosis (CF), but long-term survival is ...
Bronchiolitis obliterans syndrome (BOS) remains a major complication after lung transplantation, cau...
Objective: At the time of lung transplant, we routinely perform bronchoalveolar lavage (BAL) of the ...
Lung transplantation is the treatment of choice for patients with end-stage lung disease. However, l...
AbstractPatients with cystic fibrosis pose particular challenges for lung transplantation surgeons. ...
Bronchiolitis obliterans syndrome (BOS) is a pulmonary complication of allogeneic hematopoietic cell...
SummaryBronchiolitis obliterans syndrome (BOS) represents the leading cause of late mortality after ...
Abstract Background Chronic Lung Allograft Dysfunction (CLAD) is the main cause of morbidity and mor...
Bronchiolitis obliterans syndrome (BOS) is the main and late chronic complication after lung transpl...
BACKGROUND Acute cellular rejection (ACR) affects up to 40% of recipients within the first year afte...
International Conference of the American-Thoracic-Society (ATS), Washington, DC, MAY 19-24, 2017Inte...
Abstract Background While lung transplant (LTX) can be an effective therapy to provide the survival ...
Rationale: Bronchiolitis obliterans syndrome (BOS) is the primary limiting factor for long-term surv...
Rationale: Lung transplantation offers the only survival option for patients with cystic fibrosis (C...
Burkholderia cepacia complex (Bcc) includes several phenotypically similar but genotypically distinc...
Lung transplantation can be lifesaving in end-stage cystic fibrosis (CF), but long-term survival is ...
Bronchiolitis obliterans syndrome (BOS) remains a major complication after lung transplantation, cau...
Objective: At the time of lung transplant, we routinely perform bronchoalveolar lavage (BAL) of the ...
Lung transplantation is the treatment of choice for patients with end-stage lung disease. However, l...
AbstractPatients with cystic fibrosis pose particular challenges for lung transplantation surgeons. ...
Bronchiolitis obliterans syndrome (BOS) is a pulmonary complication of allogeneic hematopoietic cell...